Effects of methylphenidate on the behavior of male 5xFAD mice

Pharmacology Biochemistry and Behavior

Volumn 128, Issue , 2015, Pages 68-77

  Schneider, F ^a   Baldauf, K ^a   Wetzel, W ^b   Reymann, K G ^a,b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

5xFAD mice; Apathy; Cognitive deficits; Methylphenidate; Pharmacological stimulation

Indexed keywords

DOPAMINE DECARBOXYLASE; METHYLPHENIDATE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; CENTRAL STIMULANT AGENT; MUTANT PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

5XFAD MOUSE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; APATHY; AREA UNDER THE CURVE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EXPLORATORY BEHAVIOR; HABITUATION; LATENT PERIOD; LOCOMOTION; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; SHORT TERM MEMORY; SPATIAL LEARNING; SPATIAL MEMORY; ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; MAZE TEST; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY; TRANSGENIC MOUSE;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; MALE; MAZE LEARNING; METHYLPHENIDATE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTANT PROTEINS; PRESENILIN-1;

EID: 84915780322     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.11.006     Document Type: Article

References (52)

1. M. Ammassari-Teule, S. Fagioli, and C. Rossi-Arnaud Radial maze performance and open-field behaviour in aged C57BL/6 mice: further evidence for preserved cognitive abilities during senescence Physiol Behav 55 2 1994 341 345
2. A. Balcioglu, J.Q. Ren, D. McCarthy, T.J. Spencer, J. Biederman, and P.G. Bhide Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice Neuropharmacology 57 7-8 2009 687 693
3. J.D. Berke, and S.E. Hyman Addiction, dopamine, and the molecular mechanisms of memory Neuron 25 3 2000 515 532
4. J.A. Bethancourt, Z.Z. Camarena, and G.B. Britton Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats Behav Brain Res 202 1 2009 50 57
5. A. Björklund, and S.B. Dunnett Dopamine neuron systems in the brain: an update Trends Neurosci 30 5 2007 194 202
6. G.B. Britton, A.T. Segan, J. Sejour, and S.E. Mancebo Early exposure to methylphenidate increases fear responses in an aversive context in adult rats Dev Psychobiol 49 3 2007 265 275
7. S.A. Carmack, K.K. Howell, K. Rasaei, E.T. Reas, and S.G. Anagnostaras Animal model of methylphenidate's long-term memory-enhancing effects Learn Mem 21 2 2014 82 89
8. S.A. Carmack, C.L. Block, K.K. Howell, and S.G. Anagnostaras Methylphenidate enhances acquisition and retention of spatial memory Neurosci Lett 567 2014 45 50
9. N. Carrey, M.P. McFadyen, and R.E. Brown Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice J Child Adolesc Psychopharmacol 10 4 2000 277 286
10. C.A. Crawford, T. Der-Ghazarian, C.E. Britt, F.A. Varela, and O.O. Kozanian Novelty-induced conditioned place preference, sucrose preference, and elevated plus maze behavior in adult rats after repeated exposure to methylphenidate during the preweanling period Behav Brain Res 246 2013 29 35
11. D.L. Dow-Edwards, J.C. Weedon, and E. Hellmann Methylphenidate improves performance on the radial arm maze in periadolescent rats Neurotoxicol Teratol 30 5 2008 419 427
12. S. Engelborghs, and P.P. De Deyn The neurochemistry of Alzheimer's disease Acta Neurol Belg 97 2 1997 67 84
13. R. Ferreira, G.S. Bassi, A. Cabral, and M.J. Nobre Withdrawal from methylphenidate increases neural reactivity of dorsal midbrain Neurosci Res 68 4 2010 290 300
14. I. Galynker, C. Ieronimo, C. Miner, J. Rosenblum, N. Vilkas, and R. Rosenthal methylphenidate treatment of negative symptoms in patients with dementia J Neuropsychiatry Clin Neurosci 9 2 1997 231 239
15. T. Guo, C. Yang, L. Guo, and K. Liu A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD Neurosci Lett 528 1 2012 11 15
16. D.D. Han, and H.H. Gu Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs BMC Pharmacol 6 2006 6
17. C.J. Heyser, C.H. McNaughton, D. Vishnevetsky, and A.A. Fienberg Methylphenidate restores novel object recognition in DARPP-32 knockout mice Behav Brain Res 253 2013 266 273
18. P.J. Houghton, and M.J. Howes Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease Neurosignals 14 1-2 2005 6 22
19. 1 dopamine receptors in the rat striatum Brain Res 442 2 1988 349 350
20. F.L. Huang, and K.P. Huang Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice Genes Brain Behav 11 7 2012 794 805
21. S. Izenwasser, A.E. Coy, B. Ladenheim, R.J. Loeloff, J.L. Cadet, and D. French Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine Eur J Pharmacol 373 2-3 1999 187 193
22. M.L. Johnson, C.C. Ho, A.E. Day, Q.D. Walker, R. Francis, and C.M. Kuhn Oestrogen receptors enhance dopamine neurone survival in rat midbrain J Neuroendocrinol 22 4 2010 226 237
23. S. Kalinin, P.E. Polak, S.X. Lin, A.J. Sakharkar, S.C. Pandey, and D.L. Feinstein The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease Neurobiol Aging 33 8 2011 1651 1663
24. E.R. Kandel, J.H. Schwartz, and T.M. Jessell Principles of Neural Science 4th ed. 2000 Mc Graw Hill Companies New York 1009 1010 [S. 282-283, 892-893]
25. K. Koda, Y. Ago, Y. Cong, Y. Kita, K. Takuma, and T. Matsuda Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice J Neurochem 114 1 2010 259 270
26. H. Koike, D. Ibi, H. Mizoguchi, T. Nagai, A. Nitta, and K. Takuma Behavioral abnormality and pharmacologic response in social isolation-reared mice Behav Brain Res 202 1 2009 114 121
27. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J Neurochem 68 5 1997 2032 2037
28. E. Küppers, T. Ivanova, M. Karolczak, and C. Beyer Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons J Neurocytol 29 5-6 2000 375 385
29. K.L. Lanctôt, S.A. Chau, N. Herrmann, L.T. Drye, P.B. Rosenberg, and R.W. Scherer Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial Int Psychogeriatr 26 2 2013 239 246
30. R.M. Marchbanks Biochemistry of Alzheimer's dementia J Neurochem 39 1 1982 9 15
31. E.M. Marco, W. Adriani, L.A. Ruocco, A.G. Sadile, and G. Laviola Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure Neurosci Biobehav Rev 35 8 2011 1722 1739
32. H. Matthies In search of cellular mechanisms of memory Prog Neurobiol 32 4 1989 277 349
33. M.P. McFadyen-Leussis, S.P. Lewis, T.L.Y. Bond, N. Carrey, and R.E. Brown Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice Pharmacol Biochem Behav 77 3 2004 491 500
34. 1 receptors are modified by acute treatment with methylphenidate in adult mice Brain Res 1357 2010 62 69
35. M. Niculescu, M.E. Ehrlich, and E.M. Unterwald Age-specific behavioral responses to psychostimulants in mice Pharmacol Biochem Behav 82 2 2005 280 288
36. K. Niimi, C. Nishioka, T. Miyamoto, E. Takahashi, I. Miyoshi, and I. Chitoshi Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice Biochem Biophys Res Commun 406 4 2011 524 528
37. H. Oakley, S.L. Cole, S. Logan, E. Maus, P. Shao, and J. Craft Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation J Neurosci 26 40 2006 10129 10140
38. P.R. Padala, W.J. Burke, V.K. Shostrom, S.C. Bhatia, S.P. Wengel, and J.F. Potter Methylphenidate for apathy and functional status in dementia of the Alzheimer type Am J Geriatr Psychiatry 18 4 2010 371 374
39. A. Platel, and R.D. Porsolt Habituation of exploratory activity in mice: a screening test for memory enhancing drugs Psychopharmacology (Berl) 78 4 1982 346 352
40. K.J. Reinikainen, H. Soininen, and P.J. Riekkinen Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy J Neurosci Res 27 4 1990 576 586
41. K.G. Reymann, and J.U. Frey The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications Neuropharmacology 52 1 2007 24.40
42. J.S. Rhodes, and T. Garland Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior Psychopharmacology (Berl) 167 3 2003 242 250
43. S. Sadasivan, B.B. Pond, A.K. Pani, C. Qu, Y. Jiao, and R.J. Smeyne Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice PLoS One 7 3 2012 e33693
44. E.B.S. Scherer, M.J. da Cunha, C. Matté, F. Schmitz, C.A. Netto, and A.T.S. Wyse Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat Neurobiol Learn Mem 94 2 2010 247 253
45. F. Schneider, K. Baldauf, W. Wetzel, and K.G. Reymann Behavioral and EEG changes in male 5xFAD mice Physiol Behav 135 2014 25 33
46. W. Schultz Dopamine neurons and their role in reward mechanisms Curr Opin Neurobiol 7 2 1997 191 197
47. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 4 1991 487 498
48. R.C. Spencer, R.M. Klein, and C.W. Berridge Psychostimulants act within the prefrontal cortex to improve cognitive function Biol Psychiatry 72 3 2012 221 227
49. D.M.A. Van den Heuvel, and R.J. Pasterkamp Getting connected in the dopamine system Prog Neurobiol 85 1 2008 75 93
50. Y. Vermeiren, D. Van Dam, T. Aerts, S. Engelborghs, and P.P. De Deyn Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease Neurobiol Aging 2014 10.1016/j.neurobiolaging.2014.05.031 [S0197-4580(14)00397-2]
51. P.B. Yang, A.C. Swann, and N. Dafny Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats Neuropharmacology 51 3 2006 546 556
52. M. Yano, and H. Steiner Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 28 11 2007 588 596